CINECA IRIS Institutional Research Information System

ROETTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.309
AS - Asia 3.611
EU - Europa 3.067
SA - Sud America 347
AF - Africa 54
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.210
SG - Singapore 1.502
CN - Cina 1.243
IT - Italia 548
IE - Irlanda 415
SE - Svezia 346
FI - Finlandia 303
BR - Brasile 299
FR - Francia 298
DK - Danimarca 241
DE - Germania 239
UA - Ucraina 221
KR - Corea 210
VN - Vietnam 208
IN - India 113
JP - Giappone 90
GB - Regno Unito 83
PL - Polonia 80
HK - Hong Kong 75
AT - Austria 69
CA - Canada 54
BE - Belgio 49
NL - Olanda 45
ID - Indonesia 38
MX - Messico 33
ES - Italia 28
TW - Taiwan 26
AR - Argentina 24
AU - Australia 24
PT - Portogallo 18
TR - Turchia 17
CZ - Repubblica Ceca 15
RU - Federazione Russa 14
BD - Bangladesh 13
ET - Etiopia 12
RO - Romania 12
EC - Ecuador 11
CH - Svizzera 10
IQ - Iraq 10
IL - Israele 9
EG - Egitto 8
GR - Grecia 8
ZA - Sudafrica 7
LT - Lituania 6
PK - Pakistan 6
IR - Iran 5
MY - Malesia 5
EU - Europa 4
KE - Kenya 4
LB - Libano 4
MA - Marocco 4
NG - Nigeria 4
SA - Arabia Saudita 4
SN - Senegal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
HR - Croazia 3
LK - Sri Lanka 3
NO - Norvegia 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GN - Guinea 1
HU - Ungheria 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MZ - Mozambico 1
NR - Nauru 1
QA - Qatar 1
SI - Slovenia 1
Totale 13.418
Salva come PNG Salva come JPEG
Città #
Singapore 794
Chandler 727
Beijing 607
Dallas 515
Ann Arbor 445
Ashburn 424
Dublin 414
Fairfield 252
Houston 245
Santa Clara 233
Villeurbanne 215
Wilmington 167
Princeton 129
Seattle 129
Medford 127
Jacksonville 124
Turin 122
Woodbridge 120
Dearborn 116
Columbus 107
Torino 102
Cambridge 100
Nyköping 92
Pisa 82
Los Angeles 79
Warsaw 75
Buffalo 68
Boston 63
Munich 63
Redwood City 63
Boardman 61
Dong Ket 56
Vienna 51
Hong Kong 50
Shanghai 50
Pune 39
Fremont 37
Nanjing 36
Ho Chi Minh City 33
Brussels 32
Jakarta 32
Guangzhou 29
Düsseldorf 28
Hangzhou 27
San Diego 27
Wuhan 27
Hefei 26
New York 26
Turku 25
Hanoi 24
Milan 24
Tokyo 23
Redondo Beach 21
Washington 20
Phoenix 19
San Mateo 19
Seoul 19
São Paulo 19
Toronto 19
Chengdu 18
Changsha 17
Helsinki 17
Shenyang 17
Dresden 16
Norwalk 15
Nuremberg 15
Taipei 15
Jinan 13
Silver Spring 13
Stockholm 13
Waanrode 13
London 12
Montreal 12
Nanchang 12
Tianjin 12
Zhengzhou 12
Atlanta 11
Chennai 11
Rome 11
Brno 10
Chicago 10
Des Moines 10
Lappeenranta 10
Nijmegen 10
Padova 10
Chongqing 9
Falls Church 9
Hebei 9
Kunming 9
Mexico City 9
Paris 9
The Dalles 9
Asciano 7
Baghdad 7
Brooklyn 7
Rio de Janeiro 7
Amsterdam 6
Brisbane 6
Detroit 6
Heidelberg 6
Totale 8.148
Salva come PNG Salva come JPEG
Nome #
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 732
Comparison of 3 Tfr2-deficient murine models suggestsdistinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues 458
A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion 358
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 341
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form 283
Hemochromatosis due to mutations in transferrin receptor 2. 250
Analysis of microsatellite instability in chronic lymphoproliferative disorders 238
A child with hyperferritinemia: case report 234
Development of cellular and humoral response against WT1 protein vaccination in mice 224
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse 224
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis 215
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis 207
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). 199
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. 196
The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice 189
Allelic association of microsatellites of 6p in Italian hemochromatosis patients 188
The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients 184
Characterization of human mitochondrial ferritin promoter: Identification of transcription factors and evidences of epigenetic control 170
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors 167
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 158
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 151
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 144
THE PHENOTYPE OF TFR2-TMPRSS6 DOUBLE KNOCK OUT MICE ONLY PARTIALLY OVERLAPS THAT OF TMPRSS6 NULL MICE 142
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling 142
A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. 134
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA 134
Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3) 133
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells 128
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 126
Construction of a YAC contig covering human chromosome 6p22 126
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-Overload 126
COMPORTAMENTO ANSIOSO NEI TOPI TFR2 KO: NUOVO COLLEGAMENTO TRA SOVRACCARICO CEREBRALE DI FERRO E ANSIA NELLE MALATTIE NEURODEGENERATIVE? 125
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver 124
A recombination event close to HFE gene in hereditary hemochromatosis 122
Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis 119
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value 119
BBB damage in aging causes brain iron deposits via astrocyte-neuron crosstalk and Hepc/Fpn1 pathway activation 119
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 117
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging 113
Patologie da sovraccarico di ferro 113
Anemia and iron overload due to genetic defects of iron recycling, aceruloplasminemia and hemochromatosis type 4 112
Construction of a genetic map telomeric to HAL-A by microsatellite analysis 108
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 107
The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy 107
Identification of a Novel Mutation in the L Ferritin Iron-Responsive Element Causing Hereditary Hyperferritinemia-Cataract Syndrome 104
Brain iron deposits during aging: activation of the Hepc/Fpn1 pathway. 103
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. 102
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia - response to Jasperset al 102
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE) 102
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing 101
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. 101
Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study 98
Two polymorphic repeats in the candidate region for the haemochromatosis gene 95
Hereditary hemochromatosis: Generation of a transcription map within a refined and extended map of the HLA class I region 95
Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes 95
Detection of humoral immune responses against WT1 antigenin patients affected by different hematological malignancies 93
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis 92
Iron: An Essential Element of Cancer Metabolism 91
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 90
Identification of new BMP6 pro-peptide mutations in patients with iron overload 88
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. 88
TFR2 BETA ISOFORM HAS A ROLE IN CARDIAC IRON METABOLISM 87
Tfr2 KO mice show brain iron overload with microglia alterations and anxious behavior 84
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 84
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 83
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. 81
Tfr2 Beta null mice have an increase cardiac ischemia/reperfusion tolerance 80
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. 79
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation 78
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 78
Analysis of NCOA4/Tfr2 as PB markers of iron increase during ageing 78
Heterogeneity of hemochromatosis in Italy 77
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma 76
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. 75
Genetic haemochromatosis: genes and mutations associated with iron loading. 74
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. 73
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma 72
Molecular and clinical studies in hemochromatosis type 2 and 3 72
Juvenile hemochromatosis locus maps to chromosome 1q. 70
A frequent polymorphism in the 5' region of the BCMA gene 70
Juvenile and adult hemochromatosis are distinct genetic disorders 70
Commentary: Juvenile hemochromatosis in a Spanish family (by Montes-Cano et al.). 69
The natural history of hemochromatosis type 2. 69
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. 68
Mutations in transferrin receptor-2 in hemochromatosis type 3. 68
HETEROZYGOUS β-THALASSEMIA AND HOMOZYGOUS H63D HEMOCHROMATOSIS IN A CHILD: A 16-YEAR FOLLOW-UP 67
Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. 67
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. 66
Hereditary hemochromatosis: progress and perspectives 63
Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. 63
Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population. 63
Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload 63
Hereditary Hemochromatosis 62
Fisiopatologia Molecolare del Matbolismo del ferro 62
Non-HFE hemochromatosis: insights into regulation on iron metabolisms from novel iron loading disorders. 61
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients 60
Cloning of a new gene (FB19) within HLA class I region 59
Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up. 58
Natural history of juvenile haemochromatosis. 58
Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient. 56
Totale 12.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.445
article - articoli 0
book - libri 0
conference - conferenze 8.042
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021847 0 0 0 0 138 78 112 48 142 77 81 171
2021/20221.522 75 53 53 129 71 69 119 102 81 148 338 284
2022/20231.954 225 162 61 225 205 514 131 93 165 29 89 55
2023/2024858 100 170 54 70 63 129 23 45 7 45 55 97
2024/20252.364 45 120 74 261 488 133 92 135 309 154 187 366
2025/20262.123 444 161 689 495 334 0 0 0 0 0 0 0
Totale 13.817